undamentalytics Newsletter
Sign in

Sanara Medtech Inc. income statement

In fiscal 2025, Sanara Medtech Inc. reported revenue of $103m, up 19.0% on the year before, operating income of $7.3m (a 7.1% margin) and net income of −$37.6m, or −$4.36 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue121233666121624466587103110
Cost of revenue———————1112268888
Gross profit01012255511142239577996102
Research and development——————————0134355
Selling, general and administrative23—————————284657727984
General and administrative——64434561319——————
Operating income−2−5———−1−00−1−3−5−7−13−4178
Interest expense−1−0020000000000377
Income before tax−7−13−2————————−8−14−4−2−0—
Income tax———00000000—−6—0——
Net income−7−13−2−4−2−1−00−1−3−4−8−8−4−10−38−32
Diluted EPS−$9.50−$11.50−$1.50−$2.50−$1.50−$1.00−$0.50$0.00$0.00−$1.32−$0.76−$1.08−$1.00−$0.52−$1.14−$4.36−$3.70
Diluted shares (average)—1m1m2m2m2m2m2m2m2m6m7m8m8m8m9m9m
EBITDA−2−5———−1−00−0−3−5−7−10−161111

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: SMTI vs XTNTOWLT vs SMTIOM vs SMTICBLL vs SMTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sanara Medtech Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sanara Medtech Inc.